SQD.V - SQI Diagnostics Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.0900
0.0000 (0.00%)
At close: 3:50PM EDT
Stock chart is not supported by your current browser
Previous Close0.0900
Open0.0900
Bid0.0800 x 0
Ask0.0900 x 0
Day's Range0.0900 - 0.0900
52 Week Range0.0500 - 0.1800
Volume57,722
Avg. Volume53,237
Market Cap20.602M
Beta (3Y Monthly)1.77
PE Ratio (TTM)N/A
EPS (TTM)-0.0440
Earnings DateDec 9, 2019 - Dec 13, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.00
  • CNW Group

    SQI Diagnostics Inc. Announces Closing of Private Placement with Insider Participation

    OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced the closing of a previously announced non-brokered private placement (the "Private Placement") of 31,300,000 units ("Units") of the Company at a price of $0.10 per Unit for gross proceeds of $3.13 million , subject to regulatory and stock exchange approval. Each Unit consists of one common share and one common share purchase warrant.

  • CNW Group

    SQI Diagnostics Inc. Announces Private Placement with Insider Participation

    OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it intends to complete a non-brokered private placement (the "Private Placement") of up to 40,000,000 units ("Units") of the Company at a price of $0.10 per Unit for gross proceeds of up to $4 million , subject to regulatory and stock exchange approval. Each Unit will consist of one common share and one common share purchase warrant.

  • CNW Group

    SQI Diagnostics Reports Third Quarter 2019 Results

    SQI Diagnostics Reports Third Quarter 2019 Results

  • PR Newswire

    SQI Diagnostics to Announce Third Quarter 2019 Results

    TORONTO , Aug. 20, 2019 /PRNewswire/ - SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today announced that it plans to release its financial and ...

  • CNW Group

    SQI Diagnostics Inc. Closes Previously Announced Private Placement

    OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has completed its previously announced  non-brokered private placement (the "Private Placement") of 13,428,849 units ("Units") of the Company at a price of $0.13 per Unit for gross proceeds of approximately $1.75 million . Each Unit consists of one common share and one common share purchase warrant. Each common share purchase warrant entitles the holder to purchase one common share at a price of $0.17 for a period of five years from the date of issuance, subject to accelerated expiry in certain circumstances.

  • Are Insiders Buying SQI Diagnostics Inc. (CVE:SQD) Stock?
    Simply Wall St.

    Are Insiders Buying SQI Diagnostics Inc. (CVE:SQD) Stock?

    It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...

  • Have Insiders Been Buying SQI Diagnostics Inc. (CVE:SQD) Shares This Year?
    Simply Wall St.

    Have Insiders Been Buying SQI Diagnostics Inc. (CVE:SQD) Shares This Year?

    It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...

  • Is SQI Diagnostics Inc.'s (CVE:SQD) CEO Overpaid Relative To Its Peers?
    Simply Wall St.

    Is SQI Diagnostics Inc.'s (CVE:SQD) CEO Overpaid Relative To Its Peers?

    Andrew Morris became the CEO of SQI Diagnostics Inc. (CVE:SQD) in 2013. First, this article will compare CEO...

  • CNW Group

    UHN and SQI Diagnostics Successfully Test New Technology to Assess Lung Health During Transplant

    UHN and SQI Diagnostics Successfully Test New Technology to Assess Lung Health During Transplant

  • Could The SQI Diagnostics Inc. (CVE:SQD) Ownership Structure Tell Us Something Useful?
    Simply Wall St.

    Could The SQI Diagnostics Inc. (CVE:SQD) Ownership Structure Tell Us Something Useful?

    Every investor in SQI Diagnostics Inc. (CVE:SQD) should be aware of the most powerful shareholder groups. Institutions...

  • CNW Group

    SQI Diagnostics Announces Stock Option Grant

    SQI Diagnostics Announces Stock Option Grant

  • CNW Group

    SQI Diagnostics Reports Second Quarter 2019 Results

    SQI Diagnostics Reports Second Quarter 2019 Results

  • PR Newswire

    SQI Diagnostics to Announce Second Quarter 2019 Results

    TORONTO , May 2, 2019 /PRNewswire/ - SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today announced that it plans to release its financial and ...

  • CNW Group

    SQI Diagnostics Inc. Closes Second and Final Tranche of Private Placement

    OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has completed the second tranche ("Second Tranche") of a non-brokered private placement (the "Private Placement") of 2,425,000 units ("Units") of the Company at a price of $0.08 per Unit for gross proceeds of $194,000 . Each Unit consists of one common share and one common share purchase warrant. Each common share purchase warrant entitles the holder to purchase one common share at a price of $0.11 for a period of five years from the date of issuance, subject to accelerated expiry in certain circumstances.

  • CNW Group

    SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation

    OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has completed the first tranche of a non-brokered private placement (the "Private Placement") of 25,775,005 units ("Units") of the Company at a price of $0.08 per Unit for gross proceeds of approximately $2.1 million . Each Unit consists of one common share and one common share purchase warrant. Each common share purchase warrant entitles the holder to purchase one common share at a price of $0.11 for a period of five years from the date of issuance, subject to accelerated expiry in certain circumstances.

  • CNW Group

    SQI Diagnostics Reports First Quarter 2019 Results

    SQI is a Toronto -based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. Said Andrew Morris , SQI's President and CEO: "The financial results and revenue growth we continue to experience, confirms the soundness of our commercialization model.

  • PR Newswire

    SQI Diagnostics to Announce First Quarter 2019 Results

    TORONTO , Feb. 19, 2019 /PRNewswire/ - SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today announced that it plans to release its financial and ...